A new voluntary Medicare model starts in July, and it could save you $11,000 per year. But there are steps you need to take ...

A simple change in how primary care clinics approach weight management is delivering big public health wins. PATHWEIGH lets ...

Avoid these weight loss journey pitfalls with our expert tips.

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state Medicaid program? That’s what Gov. Dan McKee’s fiscal year 2027 budget suggests.

A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart health improvements within two years of stopping treatment.

A once-weekly injectable GIP/GLP-1 dual agonist conferred up to 22.5% weight loss at 48 weeks for adults with overweight or ...

Embrace your weight loss goals–and your identity as a runner—with our program.

Make your running for weight loss journey one that goes beyond the numbers.

Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may be difficult to sustain once treatment ends. Stopping treatment with weight loss medications is ...

Prediabetes can improve without weight loss when fat distribution and metabolic hormones shift in healthier ways. Many people believe that losing weight is the primary way to reduce the risk of ...